Cardiomyopathy is a chronic condition with a strong genetic component affecting at least 1 in 400 people in Europe, requiring GP involvement for identification and long-term management.
Answers are grounded in this paper and cite their sources.
May prompt greater GP focus on cardiomyopathy identification; leaves open need for updated population studies to refine estimates.
‘Cardiomyopathy’ describes disease of the heart muscle. The European Society of Cardiology (ESC) defines cardiomyopathy as ‘a myocardial disorder in which the heart muscle is structurally and functionally abnormal in the absence of coronary artery disease, hypertension, valvular disease, and congenital heart disease sufficient to explain the observed myocardial abnormality’. In Europe, approximately 1 in 400 people suffer with some form of cardiomyopathy, and this is likely to be an underestimate due to a proportion of asymptomatic patients. Cardiomyopathy often has a strong genetic component. GPs are well placed to identify high-risk individuals due to their knowledge of a patient's family history. Cardiomyopathies are chronic conditions, and GPs are therefore central in the long-term management of these patients.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: